Affinity peptides toward infliximab

US9248194B2 · kind B2 · utility

Assignee

• JANSSEN BIOTECH, INC. · US

Inventors

• Daphne Ann Salick Ryan · Manalapan, US
• John Kehoe · Schaumburg, US
• John Wheeler · Spring House, US
• Chunlin Yang · Montgomery, US
• Abla Creasy · Morristown, US

Key dates

• Filing date: Jul 23, 2014
• Grant date: Feb 2, 2016
• Expiry date: Jul 23, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

We have disclosed affinity peptides toward infliximab. More specifically we have disclosed an affinity biomatrix where the affinity peptide is covalently attached to a biocompatible, biodegradable polymer. The affinity biomatrix is useful in preparing controlled release devices for infliximab.